Literature DB >> 31439663

A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene Cyp24a1 in renal and non-renal tissues.

Mark B Meyer1, Seong Min Lee1, Alex H Carlson1, Nancy A Benkusky1, Martin Kaufmann2,3, Glenville Jones2, J Wesley Pike4.   

Abstract

Cytochrome P450 family 27 subfamily B member 1 (CYP27B1) and CYP24A1 function to maintain physiological levels of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) in the kidney. Renal Cyp27b1 and Cyp24a1 expression levels are transcriptionally regulated in a highly reciprocal manner by parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), and 1,25(OH)2D3 In contrast, Cyp24a1 regulation in nonrenal target cells (NRTCs) is limited to induction by 1,25(OH)2D3 Herein, we used ChIP-Seq analyses of mouse tissues to identify regulatory regions within the Cyp24a1 gene locus. We found an extended region downstream of Cyp24a1 containing a cluster of sites, termed C24-DS1, binding PTH-sensitive cAMP-responsive element-binding protein (CREB) and a cluster termed C24-DS2 binding the vitamin D receptor (VDR). VDR-occupied sites were present in both the kidney and NRTCs, but pCREB sites were occupied only in the kidney. We deleted each segment in the mouse and observed that although the overt phenotypes of both cluster deletions were unremarkable, RNA analysis in the C24-DS1-deleted strain revealed a loss of basal renal Cyp24a1 expression, total resistance to FGF23 and PTH regulation, and secondary suppression of renal Cyp27b1; 1,25(OH)2D3 induction remained unaffected in all tissues. In contrast, loss of the VDR cluster in the C24-DS2-deleted strain did not affect 1,25(OH)2D3 induction of renal Cyp24a1 expression yet reduced but did not eliminate Cyp24a1 responses in NRTCs. We conclude that a chromatin-based mechanism differentially regulates Cyp24a1 in the kidney and NRTCs and is essential for the specific functions of Cyp24a1 in these two tissue types.
© 2019 Meyer et al.

Entities:  

Keywords:  1,25(OH)2D3; CRISPR/Cas; ChIP-sequencing (ChIP-Seq); Cyp24a1; Cyp27b1; Cyp27b1-KO; FGF23; cytochrome P450; fibroblast growth factor (FGF); gene regulation; parathyroid hormone (PTH); vitamin D

Mesh:

Substances:

Year:  2019        PMID: 31439663      PMCID: PMC6768633          DOI: 10.1074/jbc.RA119.010173

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Regulation of the procine 1,25-dihydroxyvitamin D3-24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 and parathyroid hormone in AOK-B50 cells.

Authors:  C Zierold; G G Reinholz; J A Mings; J M Prahl; H F DeLuca
Journal:  Arch Biochem Biophys       Date:  2000-09-15       Impact factor: 4.013

2.  Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D.

Authors:  R St-Arnaud; A Arabian; R Travers; F Barletta; M Raval-Pandya; K Chapin; J Depovere; C Mathieu; S Christakos; M B Demay; F H Glorieux
Journal:  Endocrinology       Date:  2000-07       Impact factor: 4.736

3.  1,25(OH)2D, the preferred substrate for CYP24.

Authors:  Glenville Jones; Harriet S Tenenhouse
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

4.  YY1 represses vitamin D receptor-mediated 25-hydroxyvitamin D(3)24-hydroxylase transcription: relief of repression by CREB-binding protein.

Authors:  M Raval-Pandya; P Dhawan; F Barletta; S Christakos
Journal:  Mol Endocrinol       Date:  2001-06

5.  Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets.

Authors:  O Dardenne; J Prud'homme; A Arabian; F H Glorieux; R St-Arnaud
Journal:  Endocrinology       Date:  2001-07       Impact factor: 4.736

6.  Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability.

Authors:  C Zierold; J A Mings; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

7.  Expression of 25(OH)D3 24-hydroxylase in distal nephron: coordinate regulation by 1,25(OH)2D3 and cAMP or PTH.

Authors:  W Yang; P A Friedman; R Kumar; J L Omdahl; B K May; M L Siu-Caldera; G S Reddy; S Christakos
Journal:  Am J Physiol       Date:  1999-04

8.  Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase.

Authors:  Puneet Dhawan; Xiaorong Peng; Amelia L M Sutton; Paul N MacDonald; Colleen M Croniger; Christian Trautwein; Michael Centrella; Thomas L McCarthy; Sylvia Christakos
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

9.  Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.

Authors:  Sonoko Masuda; Valarie Byford; Alice Arabian; Yoshiyuki Sakai; Marie B Demay; René St-Arnaud; Glenville Jones
Journal:  Endocrinology       Date:  2004-10-21       Impact factor: 4.736

10.  Protein synthesis is required for optimal induction of 25-hydroxyvitamin D(3)-24-hydroxylase, osteocalcin, and osteopontin mRNA by 1,25-dihydroxyvitamin D(3).

Authors:  Claudia Zierold; Jamie A Mings; Jean M Prahl; Greg G Reinholz; Hector F DeLuca
Journal:  Arch Biochem Biophys       Date:  2002-08-01       Impact factor: 4.013

View more
  14 in total

1.  The unsettled science of nonrenal calcitriol production and its clinical relevance.

Authors:  J Wesley Pike; Mark B Meyer
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

2.  Calcitriol ameliorates damage in high-salt diet-induced hypertension: Evidence of communication with the gut-kidney axis.

Authors:  Ruifeng Ding; Zilong Xiao; Yufeng Jiang; Yi Yang; Yang Ji; Xunxia Bao; Kaichen Xing; Xinli Zhou; Sibo Zhu
Journal:  Exp Biol Med (Maywood)       Date:  2021-12-11

Review 3.  Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulation of Cyp27b1 and Cyp24a1 expression.

Authors:  Mark B Meyer; J Wesley Pike
Journal:  J Steroid Biochem Mol Biol       Date:  2019-10-16       Impact factor: 4.292

4.  A Control Region Near the Fibroblast Growth Factor 23 Gene Mediates Response to Phosphate, 1,25(OH)2D3, and LPS In Vivo.

Authors:  Seong Min Lee; Alex H Carlson; Melda Onal; Nancy A Benkusky; Mark B Meyer; J Wesley Pike
Journal:  Endocrinology       Date:  2019-12-01       Impact factor: 4.736

5.  Effects of 1,25 and 24,25 Vitamin D on Corneal Fibroblast VDR and Vitamin D Metabolizing and Catabolizing Enzymes.

Authors:  Xiaowen Lu; Zhong Chen; Mitchell A Watsky
Journal:  Curr Eye Res       Date:  2021-03-03       Impact factor: 2.555

6.  Vitamin D: Newer Concepts of Its Metabolism and Function at the Basic and Clinical Level.

Authors:  Daniel D Bikle
Journal:  J Endocr Soc       Date:  2020-02-08

7.  Genomic Mechanisms Governing Mineral Homeostasis and the Regulation and Maintenance of Vitamin D Metabolism.

Authors:  J Wesley Pike; Seong Min Lee; Nancy A Benkusky; Mark B Meyer
Journal:  JBMR Plus       Date:  2020-12-05

8.  Vitamin D Receptor Mediates a Myriad of Biological Actions Dependent on Its 1,25-Dihydroxyvitamin D Ligand: Distinct Regulatory Themes Revealed by Induction of Klotho and Fibroblast Growth Factor-23.

Authors:  Mark R Haussler; Sarah Livingston; Zhela L Sabir; Carol A Haussler; Peter W Jurutka
Journal:  JBMR Plus       Date:  2020-12-03

Review 9.  New Approaches to Assess Mechanisms of Action of Selective Vitamin D Analogues.

Authors:  John Wesley Pike; Mark B Meyer
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

Review 10.  Development of In Vitro and In Vivo Evaluation Systems for Vitamin D Derivatives and Their Application to Drug Discovery.

Authors:  Kaori Yasuda; Miyu Nishikawa; Hiroki Mano; Masashi Takano; Atsushi Kittaka; Shinichi Ikushiro; Toshiyuki Sakaki
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.